AzTrials
AzTrials

Chronic Obstructive Pulmonary DiseasePICCOPD+NCT01648621

Program of Integrated Care for Patients With Chronic Obstructive Pulmonary Disease and Multiple Comorbidities

A study testing 40 minute standardized education session, Individualized action plan and Individualized care plan in people with Chronic Obstructive Pulmonary Disease and Multiple Comorbidity, run by Michael Garron Hospital at 2 sites in Canada.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Many patients with chronic obstructive pulmonary disease (COPD) also have other diseases referred to as comorbidities. Often these patients require health care by a variety of health care professionals from services linked to hospitals and in the community. Read more about this study

Who is it for?
Ages 50 years and older
What is being tested?
40 minute standardized education session, Individualized action plan and Individualized care plan
Could I receive a placebo?
No, everyone receives an active treatment
How many people
470 participants
Where
2 sitesCanada
Study dates
Aug 2012to Dec 2015
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 50 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • COPD defined as chronic irreversible airflow limitation with FEV1 < lower limit of normal for age as % predicted and a FEV1/FVC ratio < than lower limit of normal (usually 70%) [5]
  • Plus ≥ 2 comorbidities commonly associated with COPD as identified in the Canadian Thoracic Society COPD guidelines
  • Cardiovascular disease
  • Osteopenia and osteoporosis
  • Glaucoma and cataracts
  • Cachexia and malnutrition
Show all 18Show fewer
  • Peripheral muscle dysfunction
  • Lung cancer
  • Metabolic syndrome (diabetes mellitus)
  • Depression
  • Chronic kidney disease OR Other conditions as primary admitting/presenting diagnosis + COPD as significant comorbidity + ≥ 1 other comorbidity
  • THAT
  • Get admitted to participating hospital; or
  • Present to participating hospital ED; or
  • Have first referral to Respiratory Centre/Respirology team
  • AND HAVE
  • ≥ 1 ED presentation/hospital admission in previous 12 months
  • ≥ 50 years age

Who cannot join

  • No access to primary care physician
  • Primary diagnosis of asthma
  • Terminal diagnosis (metastatic disease with a life expectancy of ≤ 6 months)
  • Dementia and absence of family caregiver able to assist with activation of the action plan and feedback on ongoing status and care coordination
  • Uncontrolled psychiatric illness
  • Inability to understand, read, and write English
  • No access to a phone
  • Inability to attend follow up at one of the participating sites

Trial locations and contacts

2 sites in 1 country.

Canada2 sites
  • Southlake Regional Heath Centre

    Newmarket, Ontario, L3Y 2P9

  • Toronto East General Hospital

    Toronto, Ontario, M4C 3E7

Other trials in Canada

About this study

Official title: Program of Integrated Care for Patients With Chronic Obstructive Pulmonary Disease and Multiple Comorbidities: A Randomized Controlled Trial

Many patients with chronic obstructive pulmonary disease (COPD) also have other diseases referred to as comorbidities. Often these patients require health care by a variety of health care professionals from services linked to hospitals and in the community. Unfortunately, sometimes it may be difficult for these patients to receive appropriate care in a timely manner resulting in a trip to the emergency department. As well, patients may benefit from education that enables them to recognize early signs indicating they are getting sicker and to self-manage their disease. Our study will examine a strategy that includes a case manager who will make weekly phone contact with COPD patients with comorbidity that present either to the emergency department or are admitted to hospital. Weekly contact will focus on teaching patients to recognize worsening symptoms and self-management strategies. The case manager will work with patients, caregivers, community health care providers and hospital specialists to promote communication and optimize care delivery. The investigators will examine the impact of our intervention on the need for emergency department visits and hospital admission. The investigators will also examine the impact on patients' health related quality of life, number of COPD exacerbations, and disease progression.

Being tested
40 minute standardized education session, Individualized action plan, Individualized care plan, Standardized reinforcement/motivational interviewing and action plan teach-back sessions, Tele-home monitoring
Keywords
COPD, case management
Medical subject headings
Pulmonary Disease, Chronic Obstructive

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • 40 minute standardized education sessionBehavioural

    40 minute standardized education session based on the Living Well with COPD Patient's Education Tool on study enrolment to assess and improve understanding of disease and ability to monitor symptoms and recognize exacerbation

  • Individualized action planBehavioural

    Individualized action plan using the Living Well with COPD template with patient individualized modification to address management strategies for exacerbation of comorbidity developed during the initial 40 minute session with case manager.

  • Individualized care planBehavioural

    Individualized care plan for management of COPD and comorbidities developed by the case manager in consultation with family physician and specialists.

  • Standardized reinforcement/motivational interviewing and action plan teach-back sessionsBehavioural

    Standardized reinforcement/motivational interviewing and action plan teach-back sessions based on Living Well with COPD modules as well as assessment of symptoms, progress and problems, and problem solving by phone weekly for 12 weeks, then monthly for 9 months (21 sessions) (telephone script; NOTE: case managers will make up to 3 attempts to contact participants during each week of the 12 weeks of weekly phone calls before determining inability to contact the participant for that week.

  • Tele-home monitoringBehavioural

    Tele-home monitoring of SpO2, weight, dyspnea, sputum quantity and characteristics, and general well-being for maximum of 6 months.

    Inclusion criteria for tele-home monitoring:

    1. compatible phone line b. patient consent c. patient or caregiver demonstrated ability to use monitoring equipment d. patient unable to attend outpatient/community appointments for assessment and monitoring because of environmental barriers to access (e.g. physician's office only accessible by stairs) e. severe dyspnea on activities of daily living (Medical Research Council Questionnaire for Assessing Severity of Breathlessness [MRC] Class 4 \& 5 or modified MRC [mMRC] 3 \& 4) f. frequent ED visits (> 2) in last 12 months
    2. 12 weeks of clinical stability with no ED visits.
  • Coordinated and improved communicationBehavioural

    Coordinated and improved communication between the patient, family caregivers, family physicians, specialists, and Community Care Access Centres (CCACs) facilitated by the case manager. This will include phone contact by case manager to family physicians and CCAC case manager if applicable after initial enrollment, education session and development of action plan, then monthly to report general status as well as after subsequent ED presentations/hospital admissions

  • Priority accessBehavioural

    Priority access to ambulatory clinics (Respirology and other specialties as required including Psychiatry) facilitated through the case manager.

  • Dictated patient summaryBehavioural

    Dictated patient summary sent by specialists (e.g. respirologists) to family physicians following each respiratory centre visit (every 12 weeks)

  • in-hospital rehabilitation/self-management programBehavioural

    Referral to an 8 week in-hospital rehabilitation and self-management education program for patients that are:

    1. have had a recent exacerbation, but are now clinically stable;
    2. symptomatic COPD including reduced activity levels and increased dyspnea despite pharmacological treatment;
    3. have stabilized comorbidity (no evidence of active ischemic, musculoskeletal, psychiatric or other systemic disease); and
    4. have sufficient motivation to participate.
  • Smoking cessationBehavioural

    Referral to a smoking cessation program (as applicable)

  • Action plan RespirologistBehavioural

    Individualized action plan developed with treating respirologist at the discretion of the attending respirologist.

  • Web based self management materialsBehavioural

    Referral to educational materials and resources (Living Well with COPD module printouts provided during COPD rehabilitation classes at a cost to the individual)

Study groups in NCT01648621
Study groupRoleWhat they receive
Case ManagementExperimentalIn addition to usual care, the intervention group will receive case management that includes: 40 minute standardized education session, an individualized action plan, an individualized care plan for management of COPD and comorbidities, standardized reinforcement/motivational interviewing and action plan teach-back sessions and assessment of symptoms, progress and problems, and problem solving by phone weekly for 12 weeks, then monthly for 9 months (21 sessions), tele-home monitoring, coordinated and improved communication between the patient, family caregivers, family physicians, specialists, and CCAC facilitated by the case manager, priority access to ambulatory clinics.
Receives: Behavioral: 40 minute standardized education session; Behavioral: Individualized action plan; Behavioral: Individualized care plan; Behavioral: Standardized reinforcement/motivational interviewing and action plan teach-back sessions; Behavioral: Tele-home monitoring; Behavioral: Coordinated and improved communication; Behavioral: Priority access; Behavioral: Dictated patient summary; Behavioral: in-hospital rehabilitation/self-management program; Behavioral: Smoking cessation
Usual careActive comparatorUsual care for these patients comprises: Dictated patient summary, referral to an 8 week in-hospital rehabilitation and self-management education program, referral to a smoking cessation program (as applicable), individualized action plan developed with treating respirologist at the discretion of the attending respirologist, Referral to web based educational materials and resources.
Receives: Behavioral: Dictated patient summary; Behavioral: in-hospital rehabilitation/self-management program; Behavioral: Smoking cessation; Behavioral: Action plan Respirologist; Behavioral: Web based self management materials

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The number of ED presentations

    Measured: 1 year after randomization.

Secondary outcomes (8)
  1. Hospital admission rates

    Measured: 1 year after randomization

  2. Number of hospitalized days over 1 year

    Measured: At one year after randomization

  3. Time to death

    Measured: During 12 months of intervention

  4. COPD severity measured by the BODE index

    The BODE Index is a simple grading system for COPD comprising the Six Minute Walk Distance (6MWD), the Medical Research Council Dyspnea Scale (MMRC) and body mass index (BMI).

    Measured: at baseline, 6 months and 1 year

  5. Change in health-related quality of life

    Measured using the EQ5D, St George's Respiratory Questionnaire, Hospital Anxiety and Depression Scale (HADS)

    Measured: baseline at 90 days, 6 months and 1 year

  6. Change in COPD self-efficacy scale

    The COPD SES provides items with sufficient complexity in relation to the specific situation of managing with COPD. The CSES consists of Likert scale with 5 responses from "very confident" to "not at all confident" scoring 5 to 1 with 5 representing higher self-efficacy.

    Measured: baseline at 90 days, 6 months and 1 year

  7. Patient satisfaction using the CSQ8

    Measured: 90 days, 6 months and 1 year

  8. Caregiver impact (Caregiver Impact Scale)

    This questionnaire assesses the impact of caregiving on 14 different domains (health, employment, family relations), using a 7-point Likert scale.

    Measured: at baseline, 6 months and 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Jul 2012 (estimated)
  2. Study startAug 2012
  3. Primary completionDec 2015
  4. Study completionDec 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
470 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01648621
Sponsor's protocol ID
TEGH001 PIC COPD
Acronym
PICCOPD+
Status last verified
Nov 2016
First submitted
19 Jul 2012
Last updated
11 Nov 2016
Results posted
No
Data monitoring committee
Yes

Publications

  • Poot CC, Meijer E, Kruis AL, Smidt N, Chavannes NH, Honkoop PJ. Integrated disease management interventions for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2021 Sep 8;9(9):CD009437. doi: 10.1002/14651858.CD009437.pub3.

    PubMed 34495549
  • Rose L, Istanboulian L, Carriere L, Thomas A, Lee HB, Rezaie S, Shafai R, Fraser I. Program of Integrated Care for Patients with Chronic Obstructive Pulmonary Disease and Multiple Comorbidities (PIC COPD+): a randomised controlled trial. Eur Respir J. 2018 Jan 11;51(1):1701567. doi: 10.1183/13993003.01567-2017. Print 2018 Jan.

    PubMed 29326330

Questions about this trial

What is this clinical trial studying?

A study testing 40 minute standardized education session, Individualized action plan and Individualized care plan in people with Chronic Obstructive Pulmonary Disease and Multiple Comorbidity, run by Michael Garron Hospital at 2 sites in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 18 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 11 Nov 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The number of ED presentations (time frame: 1 year after randomization.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01648621, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Nov 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in